Identification of serum microRNAs for cardiovascular risk stratification in dyslipidemia subjects

International Journal of Cardiology

Volumn 172, Issue 1, 2014, Pages 232-234

  Zhang, Chunni ^a,b   Zhang, Chen Yu ^a,b   Wu, Jia ^a   Song, Jiaxi ^a   Wang, Cheng ^a   Niu, Dongmei ^a   Li, Hanqing ^a   Liu, Yuxiu ^a   Ma, Lijuan ^a   Yu, Ruijie ^a   Chen, Xi ^a   Zen, Ke ^a   Yang, Qi ^a   Wang, Junjun ^a,b  

^a NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

Biomarker; Cardiovascular disease; Dyslipidemia; MicroRNA; Quantitative reverse transcription PCR; Risk stratification

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 146A; MICRORNA 186; MICRORNA 208B; MICRORNA 499; UNCLASSIFIED DRUG; MIRN146 MICRORNA, HUMAN; MIRN186 MICRORNA, HUMAN; MIRN208 MICRORNA, HUMAN; MIRN499 MICRORNA, HUMAN;

ACUTE CORONARY SYNDROME; ADULT; BLOOD ANALYSIS; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HIGH RISK PATIENT; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA ANALYSIS; UPREGULATION; AGED; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; GENETICS; MIDDLE AGED; RISK FACTOR;

AGED; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; RISK FACTORS;

EID: 84894102830     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.214     Document Type: Article

References (10)

1. R. Smith, T. McCready, and S. Yusuf Combination therapy to prevent cardiovascular disease: slow progress JAMA 309 2013 1595 1596
2. Emerging Risk Factors Collaboration, E. Di Angelantonio, and P. Gao et al. Lipid-related markers and cardiovascular disease prediction JAMA 307 2012 2499 2506
3. E.M. Small, and E.N. Olson Pervasive roles of microRNAs in cardiovascular biology Nature 469 2011 336 342
4. D. Quiat, and E.N. Olson MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment J Clin Invest 123 2013 11 18
5. Y. Devaux, M. Vausort, and E. Goretti et al. Use of circulating microRNAs to diagnose acute myocardial infarction Clin Chem 58 2012 559 567
6. Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults Chinese guide-lines on prevention and treatment of dyslipidemia in adults Zhonghua Xin Xue Guan Bing Za Zhi 35 2007 390 419
7. Y. Luo, C. Wang, and X. Chen et al. Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome Clin Chem 59 4 2013 658 666
8. C. Li, Z. Fang, and T. Jiang et al. Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris BMC Med Genomics 6 2013 16
9. K. Yang, Y.S. He, and X.Q. Wang et al. MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4 FEBS Lett 585 2011 854 860
10. J. Steinberger, S.R. Daniels, and R.H. Eckel et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism Circulation 119 4 2009 628 647